I agree that this site is using cookies. You can find further informations here.
X
Rebold, Nicholas
29  results:
Search for persons X
?
1

Dalbavancin Sequential Therapy for Gram-Positive Bloodstrea..:

Rebold, Nicholas ; Alosaimy, Sara ; Pearson, Jeffrey C....
Infectious Diseases and Therapy.  13 (2024)  3 - p. 565-579 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Updates in pulmonary drug‐resistant tuberculosis pharmacoth..:

Holger, Dana J. ; Althubyani, Ali ; Morrisette, Taylor..
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  44 (2024)  3 - p. 268-282 , 2024
Link: https://doi.org/10.1002/..
 
?
3

High-dose Cefepime vs Carbapenems for Bacteremia Caused by ..:

Kunz Coyne, Ashlan J ; El Ghali, Amer ; Lucas, Kristen...
Open Forum Infectious Diseases.  10 (2023)  3 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
4

Oral stepdown in Gram‐positive bloodstream infections: A st..:

Caniff, Kaylee E. ; Rebold, Nicholas ; Rybak, Michael J.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  43 (2023)  3 - p. 247-256 , 2023
Link: https://doi.org/10.1002/..
 
?
5

Risk Factors for Carbapenem-ResistantEnterobacteralesClinic..:

Rebold, Nicholas ; Lagnf, Abdalhamid M. ; Alosaimy, Sara...
Microbiology Spectrum.  11 (2023)  1 - p. , 2023
Link: https://doi.org/10.1128/..
 
?
6

Nephrotoxicity of Vancomycin in Combination With Beta-Lacta..:

Alosaimy, Sara ; Lagnf, Abdalhamid M ; Hobbs, Athena L V...
Clinical Infectious Diseases.  76 (2022)  3 - p. e1444-e1455 , 2022
Link: https://doi.org/10.1093/..
 
?
7

Clinical Characteristics Associated with Bacterial Bloodstr..:

Rebold, Nicholas ; Alosaimy, Sara ; Morrisette, Taylor...
Infectious Diseases and Therapy.  11 (2022)  3 - p. 1281-1296 , 2022
Link: https://doi.org/10.1007/..
 
?
8

Panacea or oversimplification: Relating AUC and troughs:

Rebold, Nicholas ; Lodise, Thomas ; Rybak, Michael J
American Journal of Health-System Pharmacy.  79 (2022)  12 - p. 1019-1021 , 2022
Link: https://doi.org/10.1093/..
 
?
9

Therapeutic Strategies for Emerging Multidrug-Resistant Pse..:

Kunz Coyne, Ashlan J. ; El Ghali, Amer ; Holger, Dana..
Infectious Diseases and Therapy.  11 (2022)  2 - p. 661-682 , 2022
Link: https://doi.org/10.1007/..
 
?
10

COVID-19: Before the Fall, An Evidence-Based Narrative Revi..:

Rebold, Nicholas ; Holger, Dana ; Alosaimy, Sara..
Infectious Diseases and Therapy.  10 (2021)  1 - p. 93-113 , 2021
Link: https://doi.org/10.1007/..
 
?
11

1288. Evaluation of Predictors for Clinical Success in Pati..:

Alosaimy, Sara ; Morrisette, Taylor ; Lagnf, Abdalhamid M...
Open Forum Infectious Diseases.  8 (2021)  Supplement_1 - p. S733-S733 , 2021
Link: https://doi.org/10.1093/..
 
?
12

686. Comparing Treatments of Methicillin-Resistant Staphylo..:

Rebold, Nicholas ; Alosaimy, Sara ; Lagnf, Abdalhamid M..
Open Forum Infectious Diseases.  8 (2021)  Supplement_1 - p. S445-S446 , 2021
Link: https://doi.org/10.1093/..
 
?
13

Standardized Treatment and Assessment Pathway Improves Mort..:

Alosaimy, Sara ; Lagnf, Abdalhamid M ; Morrisette, Taylor...
Open Forum Infectious Diseases.  8 (2021)  7 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
14

Early Multicenter Experience With Imipenem-Cilastatin-Releb..:

Rebold, Nicholas ; Morrisette, Taylor ; Lagnf, Abdalhamid M...
Open Forum Infectious Diseases.  8 (2021)  12 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
15

679. Traditional vs. Alternative Agents in Patients with Lo..:

Holger, Dana J ; Lagnf, Abdalhamid M ; Belza, Ana Christine...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
1-15